Juvenile Scleroderma: Apropos of Two Cases

Belde Kasap, Alper Soylu, Mehmet Türkmen, Salih Kavukçu

Issue: Volume 22 - Issue 4 - December 2007
1256 2645

Systemic Sclerosis is Not Associated with Increased Coronary Artery Calcium Deposition

Lee SEUNG-GEUN, Park YOUNG-EUN, Choi SU-YEON, Park EUN-KYUNG, Kim GEUN-TAE, Choo KI-SEOK, Jeong YEON-JOO

DOI: 10.5606/tjr.2013.3625

Issue: Volume 28 - Issue 4 - December 2013
7554 3361

Coexistence of Ankylosing Spondylitis With Morphea: A Case Report

Kevser GÜMÜŞSU, Aylin REZVANİ, Özlem SU, Nihal ÖZARAS, Mustafa GÜLER

DOI: 10.5606/ArchRheumatol.2014.3919

Issue: Volume 29 - Issue 2 - June 2014
12933 3936

Systemic Scleroderma in Childhood: A Case Report

Aslı ASLAN, Güldane KOTUROĞLU, Betül SÖZERİ, Zafer KURUGÖL

DOI: 10.5606/ArchRheumatol.2014.3684

Issue: Volume 29 - Issue 3 - September 2014
9250 3532

A Cross Sectional Study of Cardiopulmonary Complications and Severity of Pulmonary Hypertension and Lung Fibrosis in Patients With Systemic Sclerosis

Wan Ahmad Syahril Rozli WAN ALI, Mohd Shahrir MOHAMED SAID, Syahrul Sazliyana SHAHARIR, Andrea Yu Lin BAN, Rizuana Iqbal HUSSAIN, Azmillah ROSMAN

DOI: 10.5606/ArchRheumatol.2015.5593

Issue: Volume 30 - Issue 4 - December 2015
5541 2891

Clinical Usefulness of Magnetic Resonance Imaging in Four Children With Scleroderma

Kazushi AGATA, Hisashi KAWASHIMA, Atsushi KUMADA, Yasuyo KASHIWAGI, Hiroko HARA

DOI: 10.5606/ArchRheumatol.2018.6498

Issue: Volume 33 - Issue 2 - June 2018
2483 2634

Paricalcitol Inhibits Wnt/β-Catenin Signaling Pathway and Ameliorates Dermal Fibrosis in Bleomycin Induced Scleroderma Model

Nevzat GÖZEL, Fikret DURAN, Ahmet YILDIRIM, Servet YOLBAŞ, Ebru ÖNALAN, İbrahim Hanifi ÖZERCAN, Süleyman Serdar KOCA

DOI: 10.5606/ArchRheumatol.2018.6648

Issue: Volume 33 - Issue 3 - September 2018
1898 2485

Juvenile Scleroderma: A Referral Center Experience

Amra ADROVIC, Sezgin ŞAHİN, Kenan BARUT, Özgür KASAPÇOPUR

DOI: 10.5606/ArchRheumatol.2018.6578

Issue: Volume 33 - Issue 3 - September 2018
2474 2411

Antioxidant Effect of Epigallocatechin-3-Gallate in a Bleomycin-Induced Scleroderma Model

Ayse KOÇAK, Duygu HARMANCI, Zahide ÇAVDAR, Cemre URAL, Merih BİRLİK, Sülen SARIOĞLU, Osman YILMAZ, Gül GÜNER AKDOĞAN

DOI: 10.5606/ArchRheumatol.2019.6835

Issue: Volume 34 - Issue 1 - March 2019
868 1757

The Prevalence of Systemic Rheumatic Diseases Among Breast Cancer Patients and Its Relationship With Survival

Veli SUNAR, Öztürk ATEŞ, Alma KORCALI ASLAN, Yusuf KARAKAŞ, Mustafa Kadri ALTUNDAĞ

DOI: 10.5606/ArchRheumatol.2019.6803

Issue: Volume 34 - Issue 2 - June 2019
856 1231

Prevalence, Risk Factors and Assessment of Depressive Symptoms in Patients With Systemic Sclerosis

Christine MARCH, Dörte HUSCHER, Emelina PREIS, Alexander MAKOWKA, Jakob HOEPPNER, Frank BUTTGEREIT, Gabriela RIEMEKASTEN, Kristina NORMAN, Elise SIEGERT

DOI: 10.5606/ArchRheumatol.2019.7111

Issue: Volume 34 - Issue 3 - September 2019
720 1074

A Real-World Experience of Mycophenolate Mofetil for Systemic Sclerosis: A Retrospective Multicenter Observational Study

Kyung-Ann LEE, Bo Young KIM, Sung Jae CHOI, Seong-Kyu KIM, Sang-Hyon KIM, Hyun-Sook KIM

DOI: 10.46497/ArchRheumatol.2020.7771

Issue: Volume 35 - Issue 3 - September 2020
610 617

A preliminary study of possible fibrotic role of meprin metalloproteases in scleroderma patients

Ayşe Koçak, Aydan Köken Avşar, Duygu Harmancı, Gül Akdoğan, A. Merih Birlik

DOI: 10.46497/ArchRheumatol.2021.8581

Issue: Online First
0 408

Screening and identification of potential biomarkers and therapeutic targets for systemic sclerosis-associated interstitial lung disease

Biqing Huang, Jing Li, Jiuliang Zhao

DOI: 10.46497/ArchRheumatol.2021.8625

Issue: Online First
0 358